Related Experiment Video
Updated: Jun 23, 2026
05:51
A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
Published on: May 6, 2014
Innate and adaptive immunity in atherosclerosis
René R S Packard1, Andrew H Lichtman, Peter Libby
1Leducq Center for Cardiovascular Research, Division of Cardiovascular Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, NRB 7, Boston, MA 02115, USA.
Seminars in Immunopathology
|May 19, 2009
Summary
Atherosclerosis is an inflammatory disease involving the immune system, leading to plaque rupture and thrombotic events like heart attack or stroke. Understanding immune mechanisms offers new therapeutic targets for cardiovascular risk.
Area of Science:
- Immunology
- Cardiovascular Medicine
- Inflammation Biology
Background:
- Atherosclerosis is a chronic inflammatory condition impacting innate and adaptive immunity.
- Plaque rupture or erosion, driven by inflammation, causes fatal thromboses (myocardial infarction, ischemic stroke).
- C-reactive protein and statins highlight the role of inflammation in cardiovascular risk.
Purpose of the Study:
- To review the immune mechanisms underlying atherosclerosis.
- To explore the roles of innate and adaptive immunity in atherogenesis.
- To identify future strategies for risk stratification and anti-inflammatory therapies.
Main Methods:
- Literature review focusing on immune cell subsets in atherosclerosis.
- Analysis of the contribution of leukocytes to atherogenesis.
- Synthesis of current understanding of inflammatory pathways in plaque development.
Main Results:
- Innate and adaptive immune cells are integral to atherosclerosis initiation, progression, and thrombotic complications.
- Inflammatory activity within plaques is a key determinant of rupture-prone lesions.
- Leukocyte subsets play critical roles throughout the atherogenic process.
Conclusions:
- Atherosclerosis pathogenesis is deeply intertwined with immune system activity.
- Targeting immune mechanisms holds promise for novel anti-atherosclerotic therapies.
- Further research into immune pathways can improve patient risk stratification and treatment.
Related Concept Videos
01:30Atherosclerosis I: Introduction
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
01:38Inflammation
Overview
01:26Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
01:21Introduction to Innate and Adaptive Immunity
The human immune system is a complex defense mechanism that protects the body from harmful pathogens and foreign substances. It comprises two crucial components: innate and adaptive immunity.
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
Innate immunity is the body's natural, nonspecific defense system that acts quickly to protect against pathogens. It incorporates physical barriers like skin and mucous membranes and cellular elements such as phagocytes and natural killer cells. This part of our immune system provides an immediate,...
01:27Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
01:26Atherosclerosis III: Management
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...